Evaluation of Periodontal Status in Women with Polycystic Ovary Syndrome Versus Healthy Women: a Cross-sectional Study

Overview

Journal J Yeungnam Med Sci

Specialty General Medicine

Date 2023 May 9

PMID 37157778

Authors

Sandhya Pavankumar

Pavan Kumar Yellarthi

Sandeep Jn

Ramanarayana Boyapati

Trinath Kishore Damera

Naveen Vital Kumar G

Affiliations

Soon will be listed here.

Abstract

Background: Polycystic ovary syndrome (PCOS) affects approximately 4% to 12% of females of reproductive age. Previous studies have shown an association between systemic and periodontal diseases. This study aimed to compare the prevalence of periodontal disease in women with PCOS and healthy women.

Methods: A total of 196 women aged 17 to 45 years were included in this study. Oral hygiene index-simplified (OHI-S), gingival index (GI), community periodontal index (CPI), and loss of attachment (LA) were assessed. Individuals who smoked, were pregnant, had any systemic disease (such as type 1 or type 2 diabetes mellitus, cardiovascular disease, malignancy, osteoporosis, and thyroid dysfunction), had a history of systemic antibiotic use in the past three months, or received any periodontal intervention in the past 6 months of screening were excluded. Student t-test was used to analyze the data. A p-value of <0.05 was considered statistically significant.

Results: Despite similar OHI-S scores (p=0.972) in the two groups, women with PCOS had significantly higher GI, CPI, and LA scores than healthy women (p<0.001).

Conclusion: Periodontal disease was more prevalent in women with PCOS than in healthy women. This finding may be due to the synergistic effects of PCOS and periodontitis on proinflammatory cytokines. PCOS may have an effect on periodontal disease, and vice versa. Hence, education on periodontal health and early detection and intervention for periodontal diseases is of paramount importance in patients with PCOS.

Citing Articles

Insight of the interrelationship and association mechanism between periodontitis and diabetes mellitus.

Yang Y, Sun X, Yang Y, Qie Y Regen Ther. 2024; 26:1159-1167.

PMID: 39640921 PMC: 11617686. DOI: 10.1016/j.reth.2024.11.001.

References

Gambineri A, Pelusi C, Vicennati V, Pagotto U, Pasquali R . Obesity and the polycystic ovary syndrome. Int J Obes Relat Metab Disord. 2002; 26(7):883-96. DOI: 10.1038/sj.ijo.0801994. View

Duleba A, Dokras A . Is PCOS an inflammatory process?. Fertil Steril. 2011; 97(1):7-12. PMC: 3245829. DOI: 10.1016/j.fertnstert.2011.11.023. View

Diamanti-Kandarakis E, Alexandraki K, Piperi C, Protogerou A, Katsikis I, Paterakis T . Inflammatory and endothelial markers in women with polycystic ovary syndrome. Eur J Clin Invest. 2006; 36(10):691-7. DOI: 10.1111/j.1365-2362.2006.01712.x. View

Sabuncu T, Vural H, Harma M . Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease. Clin Biochem. 2001; 34(5):407-13. DOI: 10.1016/s0009-9120(01)00245-4. View

Kuscu N, Var A . Oxidative stress but not endothelial dysfunction exists in non-obese, young group of patients with polycystic ovary syndrome. Acta Obstet Gynecol Scand. 2009; 88(5):612-7. DOI: 10.1080/00016340902859315. View

Sheehan M . Polycystic ovarian syndrome: diagnosis and management. Clin Med Res. 2005; 2(1):13-27. PMC: 1069067. DOI: 10.3121/cmr.2.1.13. View

Carmina E, Bucchieri S, Esposito A, Del Puente A, Mansueto P, Orio F . Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance. J Clin Endocrinol Metab. 2007; 92(7):2500-5. DOI: 10.1210/jc.2006-2725. View

Ruan H, Lodish H . Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-alpha. Cytokine Growth Factor Rev. 2003; 14(5):447-55. DOI: 10.1016/s1359-6101(03)00052-2. View

Diamanti-Kandarakis E, Piouka A, Livadas S, Piperi C, Katsikis I, Papavassiliou A . Anti-mullerian hormone is associated with advanced glycosylated end products in lean women with polycystic ovary syndrome. Eur J Endocrinol. 2009; 160(5):847-53. DOI: 10.1530/EJE-08-0510. View

10.

Yudkin J, Stehouwer C, Emeis J, Coppack S . C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?. Arterioscler Thromb Vasc Biol. 1999; 19(4):972-8. DOI: 10.1161/01.atv.19.4.972. View

11.

Ozcaka O, Buduneli N, Ceyhan B, Akcali A, Hannah V, Nile C . Is interleukin-17 involved in the interaction between polycystic ovary syndrome and gingival inflammation?. J Periodontol. 2013; 84(12):1827-37. DOI: 10.1902/jop.2013.120483. View

12.

Franks S . Polycystic ovary syndrome. N Engl J Med. 1995; 333(13):853-61. DOI: 10.1056/NEJM199509283331307. View

13.

Dinger Y, Akcay T, Erdem T, Saygili E, Gundogdu S . DNA damage, DNA susceptibility to oxidation and glutathione level in women with polycystic ovary syndrome. Scand J Clin Lab Invest. 2006; 65(8):721-8. DOI: 10.1080/00365510500375263. View

14.

Knochenhauer E, Key T, Kahsar-Miller M, Waggoner W, Boots L, Azziz R . Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab. 1998; 83(9):3078-82. DOI: 10.1210/jcem.83.9.5090. View

15.

Porwal S, Tewari S, Sharma R, Singhal S, Narula S . Periodontal status and high-sensitivity C-reactive protein levels in polycystic ovary syndrome with and without medical treatment. J Periodontol. 2014; 85(10):1380-9. DOI: 10.1902/jop.2014.130756. View

16.

Rahiminejad M, Moaddab A, Zaryoun H, Rabiee S, Moaddab A, Khodadoustan A . Comparison of prevalence of periodontal disease in women with polycystic ovary syndrome and healthy controls. Dent Res J (Isfahan). 2016; 12(6):507-12. PMC: 4696351. DOI: 10.4103/1735-3327.170547. View

17.

Festa A, DAgostino Jr R, Howard G, Mykkanen L, Tracy R, Haffner S . Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation. 2000; 102(1):42-7. DOI: 10.1161/01.cir.102.1.42. View

18.

Diamanti-Kandarakis E, Katsikis I, Piperi C, Kandaraki E, Piouka A, Papavassiliou A . Increased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome (PCOS). Clin Endocrinol (Oxf). 2008; 69(4):634-41. DOI: 10.1111/j.1365-2265.2008.03247.x. View

19.

Isik Y, Telatar G, Neselioglu S, Bicer C, Gurlek B . Evaluation of periodontal status in different phenotypes of polycystic ovary syndrome in untreated patients of early reproductive age: A case-control study. J Obstet Gynaecol Res. 2020; 46(3):459-465. DOI: 10.1111/jog.14179. View

20.

Ozcaka O, Ceyhan B, Akcali A, Bicakci N, Lappin D, Buduneli N . Is there an interaction between polycystic ovary syndrome and gingival inflammation?. J Periodontol. 2012; 83(12):1529-37. DOI: 10.1902/jop.2012.110588. View